Concr

Concr has been a member of Linktree for 2 years and joined in June 2023. The social media accounts linked to from Concr are: LinkedIn, Email. Besides social media accounts, concrspace has populated their site with Transparent AI in Clinical Trials, Digital Controls for Cancer Drug Trials, The New Reality of Living Long with Cancer: Interviewing Andrew Biankin, Interview with 9AM Business, FarrSight® Platform for Drug Developers, Personalised therapy in CUP: A feasibility study of Bayesian AI digital twins using ctDNA, Artificial intelligence’s role in cancer diagnosis, Using AI-generated molecular digital twins to predict chemotherapy response in cancer, Conserved facultative heterochromatin across cell types identify regulatory sequences underpinning cell identity and disease | Nucleic Acids Research | Oxford Academic, The Dark Matter of Oncology - SoTA Letters, Bayesian Digital Twins Show Potential For Predicting Prognosis And Treatment Response, How Bayesian-inspired uncertainty management could shape the future of trustworthy AI -, Bayesian Theory, Oncology & Digital Twins for Cancer: Irina Babina, Concr, Personalised therapy in triple-negative breast cancer with Bayesian Digital Twins, Brief report: Unlocking the potential of ‘other’ cancers, Partner pre-publication: Epigenetic constraint of cellular genomes links genetic variation to function, Nouveaux résultats suggérant l'intérêt d'un "jumeau numérique" pour choisir le meilleur anticancéreux - TICpharma, In press: The Times, In press: genomeweb, Schedule a meeting / demo, A Bayesian foundation model of cancer biology predicts optimal treatment for individual patients and clinical trial results., Personalised therapy in CUP: a feasibility study of Bayesian AI Digital Twins using ctDNA, Scientists Develop a ‘Digital Twin’ Model to Predict Cancer Treatment Responses - ASCO Post, 'Digital twin' could help predict how well cancer treatments may work - Scimex, Digital twins of cancer patients predict effectiveness of treatments - The Engineer, Late-Breaking Abstract: ENA Symposium Poster on AML #517, Concr to present latest results at ENA-2024, Patient Data Is an Asset and a Liability—Experts Advice, NHS, academia & industry unite on digital health innovation, ‘Going into industry’ is still a dirty phrase for academia. We need to change this | Sifted, Podcast: From Dark Matter to Digital Twins, Already using Scientist.com? Submit your request directly, Regulating complexity in AI-enabled omics and multi-omics technologies for precision medicine | npj Digital Medicine, PharmaPhorum: How predictive analysis can shift the research imbalance, Europe's emerging cancer tech startups: Concr, Cambridge Enterprise features Concr in review, Cambridge Angels interviews Concr's CEO, Concr is Hello Tomorrow finalist!, Application of digital twins for personalized oncology - Nature Reviews Cancer, Improving outcomes of patients with pancreatic cancer - Nature Reviews Clinical Oncology, Sifted spotlight on Concr, Feature: European HealthTech Market Map 2025 - AlbionVC, Technology Networks Feature: How Astrophysics Is Powering Cancer Innovation, Predicting tissue of origin from somatic mutation features, A prognostic machine learning model for early breast cancer, Identification and differentiation of cells from H&E slides in breast cancer, AACR posters, Cure: Breaking Cancer’s Breakthrough Bottleneck, Blueprint for Change: shaping the future of clinical development, Introduction to Concr, Improving Precision Oncology - Concr's approach, Concr announces new partnership with CariGenetics, First patients recruited to Concr's trial of response prediction in breast cancer, New government tech deals boost the business of cancer detection, Concr secures Innovate UK grant, Concr predicts trial outcomes in silico, Two trials reveal ‘hidden’ cancer for Christie patient, Partnerships, Latest news, About us.